Welcome to the Hologic Investor Relations page
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.
The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".
Wednesday, February 4, 2015
Hologic to Present at Three Upcoming Investor Conferences
Tuesday, January 20, 2015
Hologic Announces Additions to Executive Leadership Team
Tuesday, January 13, 2015
CEO Stephen MacMillan on Fox Business News
Monday, January 5, 2015
Hologic to Announce Financial Results for the First Quarter of Fiscal 2015 on Wednesday, January 28, 2015
Monday, December 1, 2014
Hologic Enters the Viral Load Market with CE Mark Certification for the Aptima HIV-1 Viral Load Test
Thursday, November 6, 2014
President and CEO Steve MacMillan on CNBC Squawk Box